Diagnosis and treatment of unexplained infertility. Rev Obstet Gynaecol 2008 Spring;1(2):69-76.
Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci 2011 May;4(2):86-90.
The evaluation of the role of follicle stimulating hormone receptor (FSHR) gene polymorphism in controlling ovarian hyperstimulation. J Am Sci 2011;7(10):91-99.
Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010 Mar-Apr;16(2):113-130.
Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti Müllerian hormone levels in normoovulatory women. J Korean Med Sci 2015 Mar;30(3):296-300.
Body Mass Index and success rate of IVF. J Fam and Reprod Health 2007; 1:41-46.
Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH. Hum Reprod 2000 Jul;15(7):1452-1456.
Intensive hormone monitoring in women with unexplained infertility: evidence for subtle abnormalities suggestive of diminished ovarian reserve. Fertil Steril 1997 Sep;68(3):413-420.
The value of different ovarian reserve tests in the prediction of ovarian response in patients with unexplained infertility. Middle East Fertil Soc J 2016 Jun;21(2):69-74.
Elevated day 3 follicle stimulating hormone/luteinizing hormone ratio 2 is associated with higher rates of cancellation in vitro fertilization embryo transfer cycles. Fertil Steril 2008;90:297-301.
Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women. J Assist Reprod Genet 2012 Mar;29(3):231-236.
High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet 2001 Sep;18(9):499-505.
Unexplained infertility: evaluation of the luteal phase; results of the National Center for Infertility Research at Michigan. Fertil Steril 1997 Mar;67(3):437-442.
Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/ intra-uterine insemination cycles. Hum Reprod 1996 Jun;11(6):1214-1219.
Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril 1997 Aug;68(2):272-277.
Inhibin B and anti Mullerian hormone: markers of ovarian response IVF/ICSI patients? BJOG 2004 Nov;111(11):1248-1253.
Serum anti Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006 Dec;21(12):3103-3107.
Anti Müllerian hormone as a predictor of IVF outcome. Reprod Biomed Online 2007 May;14(5):602-610.
